Is Microneedle Therapy Effective? — Intelligent Breakthroughs From The Perspective Of Technological Innovation

 The effectiveness of microneedle therapy largely depends on the degree of innovation of the technology itself. With the integrated development of materials science, nanotechnology and intelligent healthcare, microneedle technology has evolved from a simple physical puncture tool into an intelligent medical platform integrating diagnosis, treatment and monitoring. From the perspective of technological innovation, this paper explores the scientific and technological support behind the efficacy of microneedle therapy. ## Breakthrough Progress in Intelligent Microneedle Systems In 2025, the field of microneedle technology witnessed multiple groundbreaking innovations. A research team specializing in nanomedicine and biomaterials at South China University of Technology developed a **Flexible Bioelectronic Microneedle Patch (FBMP)**. Integrated with flexible electronic components, it enables actively controlled transdermal delivery. Combining flexible printed circuit boards, eutectic gallium-indium heating films, and double-layer microneedles with a polyvinyl alcohol core and polycaprolactone shell, the patch supports wireless control via smartphones to adjust drug release rates in real time. It achieves rapid drug release within 2 minutes or sustained release over 10 hours. The core innovation of this technology lies in the integration of microneedle and flexible electronics, enabling customizable and actively regulated drug delivery. Validated in various animal models, FBMP demonstrates universal applicability in delivering multiple types of drugs, optimizing therapeutic efficacy and reducing side effects. Its rapid-release capability was verified in treating mouse acute shock models and performing rapid local anesthesia. In melanoma models, co-sustained delivery of IFN-γ and BRD4-targeting PROTAC drugs via FBMP inhibited IFN-γ-induced PD-L1 upregulation, thereby enhancing immunotherapeutic outcomes. ## Responsive Microneedles: Environmental Intelligent Sensing and Precision Release The **missile-like microneedle** system developed by Professor Yi Yangyan's team from the Second Affiliated Hospital of Nanchang University represents another major breakthrough in microneedle technology. This bionic double-layer microneedle system actively responds to the wound microenvironment and releases drugs on demand to realize sequential therapy. Targeting the clinical challenge of refractory chronic diabetic wounds, the system innovatively builds an intelligent platform enabling integrated treatment of **antibiosis, immune regulation and tissue repair promotion**. By combining advanced nanomaterials with sophisticated microneedle design, the research constructs an intelligent system capable of active microenvironmental response, on-demand drug release and sequential intervention. It not only embodies innovations in material design but also provides a new approach of **multi-target synergy and integrated therapy** for complex diseases such as chronic diabetic wounds, showing broad prospects for clinical translation. Environment-responsive microneedles can intelligently adjust the type and release rate of drugs according to wound pH, enzymatic activity, bacterial concentration and other indicators, achieving genuine precise treatment. ## Development of Multifunctional Integrated Microneedle Platforms Research teams from Nanjing Tech University and the National University of Singapore systematically reviewed key advances in the integration of microneedles and microfluidics for intelligent wearable medical devices. The study focuses on the organic combination of microneedles - featuring excellent minimally invasive puncture performance - and microfluidic systems capable of precise liquid manipulation, aiming to develop next-generation intelligent wearables integrating real-time monitoring, biological signal collection and drug delivery. The authors elaborate on mainstream microneedle structural types, including hollow, porous, bionic and multi-layer composite designs, and analyze their key roles in enhancing biocompatibility, mechanical performance, responsive drug delivery and intelligent sensing. The paper points out that using microneedles as the **interface** of microfluidic systems not only significantly improves the efficiency and accuracy of body fluid collection but also provides technical support for closed-loop therapy, such as glucose monitoring and insulin delivery systems. Special emphasis is placed on the innovative design of bionic microneedles in drug release regulation, tissue adhesion and triboelectric actuation, laying a foundation for building intelligent treatment platforms with adaptive feedback and regulation capabilities. ## Technological Breakthroughs in Gene Therapy and Cell Delivery Microneedle technology has also achieved remarkable progress in gene therapy and cell delivery. A 2025 study published in *Nature Communications* introduced a wearable flexible ultrasound-driven microneedle patch (wf-UMP) - a portable platform for convenient, efficient and minimally invasive cancer treatment. In preclinical mouse studies, wf-UMP exerted significant anti-tumor effects by inducing tumor cell apoptosis, amplifying oxidative stress and regulating immune cell proliferation. More notably, the combined immunotherapy of wf-UMP and Anti-PD1 further enhanced anti-cancer immunity by activating immunogenic cell death and modulating macrophage polarization, inhibiting distant tumor growth and tumor recurrence. This platform integrating ultrasound and microneedle technology opens new possibilities for cancer immunotherapy. In the field of cell delivery, cryogenic microneedle technology developed by scientists at City University of Hong Kong is driving microneedle innovation to a new level. Less than 1 millimeter in length, these frozen microneedle devices can encapsulate and store viable mammalian cells inside the needle body. During administration, the cryogenic microneedle patch adheres directly to the skin, penetrates the stratum corneum briefly and embeds into the epidermis or superficial dermis. The needle body then detaches from the substrate, and the frozen structure melts rapidly at body temperature to release encapsulated viable cells. These cells migrate, colonize and proliferate in skin tissues, realizing genuine cellular implantation therapy. ## Innovation-Driven Progress in Materials Science The efficacy of microneedle technology relies heavily on advances in materials science. A novel **bipolar microneedle** material developed by Lanzhou University operates based on galvanic cell principles. It can self-power when attached to the skin, generating mild electric current while releasing hydrogen and magnesium ions. These effects eliminate free radicals, relieve inflammation, and promote cell repair, angiogenesis and collagen synthesis, ultimately restoring skin health and reducing wrinkles. Professor Zhang Yu's team at Shenyang Pharmaceutical University constructed self-oxygenating core-shell structured microneedle patches for precise local delivery of BRD4 PROTAC molecules, the photosensitizer verteporfin and calcium peroxide nanoparticles to post-operative melanoma lesions. The constructed AV@LDL&CaO₂ microneedle platform significantly enhances tumor immunogenicity and reverses the immunosuppressive tumor microenvironment. It achieves precise treatment of post-operative melanoma with low dosage, low toxicity and high efficacy, while offering the advantages of simple administration and high patient compliance. ## Precision Development of Manufacturing Processes The progress of microneedle manufacturing processes is directly related to their efficacy and safety. Transdermal microneedles are mainly categorized into three types: dissolvable, solid and hollow, fabricated from silicon, metal or biodegradable polymers with needle lengths ranging from 50 to 1500 micrometers. Manufacturing techniques include photolithography, micromolding and 3D printing, which guarantee needle uniformity and mechanical strength. All products must pass skin irritation and biocompatibility tests to ensure safety. A bistable suction cup device combined with drug-loaded microneedles, developed by the Chang Hao research team, further improves drug delivery efficiency. Fabricated from biocompatible and highly elastic polydimethylsiloxane, the device flips its shell structure; after microneedle puncture and skin attachment, gentle edge pressing triggers rapid structural rebound to its stable original state. Local negative pressure is formed inside the cavity, acting like an active micropump. It adheres closely to the skin by uplifting a small portion of tissue, accelerates complete microneedle dissolution for 100% drug release, and promotes intradermal drug diffusion. In animal experiments, traditional medical adhesive tapes achieve approximately 63% drug bioavailability for fixed microneedles, while this device raises the utilization rate to over 98%. ## Development Trends of Intelligence and Personalization In the future, transdermal microneedles will evolve toward multifunctional integration, intelligent response and personalized customization. Next-generation microneedle arrays will integrate temperature-sensitive, pH-responsive or light-controlled materials to realize on-demand and precisely regulated drug release. Diagnostic and therapeutic functions will be integrated to develop **theranostic microneedles** that enable simultaneous sample collection and drug administration. 3D bioprinting will support customized microneedle design based on individual skin characteristics, improving fitting performance and overall efficacy. Nanjing Tech University's research team proposes that the integration of AI algorithms, wearable communication modules and biocompatible energy systems is expected to realize a full closed-loop precision healthcare model covering **diagnosis, decision-making and intervention**. Such intelligent microneedle systems can monitor patients' physiological parameters in real time, automatically adjust treatment regimens based on data analysis, and deliver truly personalized medical care. ## Conclusion: Technological Innovation Drives Efficacy Improvement From the perspective of technological innovation, the efficacy of microneedle therapy is continuously strengthened by a series of groundbreaking advances. Innovations including intelligent microneedle systems, environment-responsive microneedles, multifunctional integrated platforms, and gene and cell delivery technologies are transforming microneedles from simple drug delivery tools into comprehensive intelligent medical platforms. These technological advances not only enhance therapeutic efficacy but also expand application boundaries, enabling microneedles to address more complex medical challenges. Progress in materials science, refined manufacturing processes and intelligent integration jointly propel microneedle technology to higher levels. With technological maturity and commercialization, microneedle therapy is expected to play a vital role in more disease fields, providing patients with safer, more effective and convenient treatment options. The value of microneedle technology lies not only in its immediate clinical efficacy but also in its potential for continuous innovation, making it one of the most promising development directions in modern medical technology.